Eloctate
- Generic Name: antihemophilic factor (recombinant), fc fusion protein for intravenous infusion
- Brand Name: Eloctate
Eloctate (Antihemophilic Factor (Recombinant), Fc Fusion Protein for Intravenous Infusion) side effects drug center
Eloctate Side Effects Center
Eloctate [Antihemophilic Factor (Recombinant), Fc Fusion Protein] used in adults and children with Hemophilia A (congenital Factor VIII deficiency) to control and prevent bleeding episodes, for perioperative management (surgical prophylaxis), and routine prophylaxis to prevent or reduce the frequency of bleeding episodes. Eloctate is not indicated for the treatment of von Willebrand disease. Common side effects of Eloctate include:

